Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("highly active antiretroviral therapy")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 281

  • Page / 12
Export

Selection :

  • and

Chinese Pediatric Highly Active Antiretroviral Therapy Observational Cohort : A 1-Year Analysis of Clinical, Immunologic, and Virologic OutcomesFUJIE ZHANG; HABERER, Jessica E; YAN ZHAO et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 5, pp 594-598, issn 1525-4135, 5 p.Article

Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MDKAVASERY, Ravi; GALAI, Noya; ASTEMBORSKI, Jacquie et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 4, pp 360-366, issn 1525-4135, 7 p.Article

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002MOORE, Richard D; KERULY, Jeanne C; GEBO, Kelly A et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 195-198, issn 1525-4135, 4 p.Article

Virological rebound after suppression on highly active antiretroviral therapyMOCROFT, Amanda; RUIZ, Lidia; REISS, Peter et al.AIDS (London). 2003, Vol 17, Num 12, pp 1741-1751, issn 0269-9370, 11 p.Article

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy : PISCIS Cohort (Spain)JAEN, Angeles; ESTEVE, Anna; VILARO, Josep et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 212-220, issn 1525-4135, 9 p.Article

Prevalent Pregnancy, Biological Sex, and Virologic Response to Antiretroviral TherapyWESTREICH, Daniel; EVANS, Denise; FIRNHABER, Cindy et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 5, pp 489-494, issn 1525-4135, 6 p.Article

Optimal Time on HAART for Prevention of Mother-to-Child Transmission of HIVCHIBWESHA, Carla J; GIGANTI, Mark J; PUTTA, Nande et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 2, pp 224-228, issn 1525-4135, 5 p.Article

Clinical Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral TherapyRUIMIN TAN; WESTFALL, Andrew O; WILLIG, James H et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 553-558, issn 1525-4135, 6 p.Article

Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free SurvivalHENDRICKSON, Sher L; JACOBSON, Lisa P; O'BRIEN, Stephen J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 3, pp 263-271, issn 1525-4135, 9 p.Article

LMNA messenger RNA expression in highly active antiretroviral therapy-treated HIV-positive patientsMIRANDA, Merce; CHACON, Matilde R; VIDAL, Francesc et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 4, pp 384-389, issn 1525-4135, 6 p.Article

A retrospective study to determine the impact of medical- and lifestyle-based contraindications to a prescribed HAART regimen on clinical outcomes and adherenceLAL, L. S; GRIMES, R. M; SWINT, J. M et al.Journal of clinical pharmacy and therapeutics (Print). 2006, Vol 31, Num 5, pp 429-439, issn 0269-4727, 11 p.Article

Capacity of health-care facilities to deliver HIV treatment and care services, Northern Tanzania, 2004LANDMAN, Keren Z; KINABO, Grace D; SCHIMANA, Werner et al.International journal of STD & AIDS. 2006, Vol 17, Num 7, pp 459-462, issn 0956-4624, 4 p.Article

Critical care of immunocompromised patients : Human immunodeficiency virusROSEN, Mark J; NARASIMHAN, Mangala.Critical care medicine. 2006, Vol 34, Num 9, issn 0090-3493, S245-S250, SUPArticle

The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in womenANASTOS, Kathryn; SCHNEIDER, Michael F; GANGE, Stephen J et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 5, pp 537-544, issn 1525-4135, 8 p.Article

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: Survival and risk factors of deathWYEN, Christoph; HOFFMANN, Christian; SCHMITZ, Karina et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 2, pp 1263-1268, issn 1525-4135, 6 p.Article

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in The NetherlandsNELLEN, Jeannine F; WIT, Ferdinand W; DE WOLF, Frank et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 4, pp 943-950, issn 1525-4135, 8 p.Article

Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapySCEVOLA, Daniele; DI MATTEO, Angela; LANZARINI, Paolo et al.AIDS (Supplement). 2003, Vol 17, pp S123-S129, issn 1350-2840, SUP1Article

HIV as a chronic diseaseMAHUNGU, Tabitha W; RODGER, Alison J; JOHNSON, Margaret A et al.Clinical medicine. 2009, Vol 9, Num 2, pp 125-128, issn 1470-2118, 4 p.Article

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAARTWEINTROB, Amy C; FIEBERG, Ann M; AGAN, Brian K et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 1, pp 40-47, issn 1525-4135, 8 p.Article

Long-Term Survival and Serious Cardiovascular Events in HIV-Infected Patients Treated With Highly Active Antiretroviral TherapyBOZZETTE, Samuel A; AKE, Christopher F; TAM, Henry K et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 3, pp 338-341, issn 1525-4135, 4 p.Article

Discontinuation and modification of highly active antiretroviral therapy in HIV-infected ugandans: Prevalence and associated factorsKIGUBA, Ronald; BYAKIKA-TUSIIME, Jayne; KARAMAGI, Charles et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 218-223, issn 1525-4135, 6 p.Article

Trends in opportunistic infections in the pre-and post-highly active antiretroviral therapy eras among HIV-infected children in the perinatal AIDS collaborative transmission study, 1986-2004NESHEIM, Steven R; KAPOGIANNIS, Bill G; SOE, Minn M et al.Pediatrics (Evanston). 2007, Vol 120, Num 1, pp 100-109, issn 0031-4005, 10 p.Article

Antiretroviral adherence, drug resistance, viral fitness and hiv disease progression : a tangled web is wovenLUCAS, Gregory M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 4, pp 413-416, issn 0305-7453, 4 p.Article

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapyBENITO, José Miguel; LOPEZ, Mariola; LOZANO, Sara et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 4, pp 373-381, issn 1525-4135, 9 p.Article

Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003CAMPOS, Dayse Pereira; ROCHA RIBEIRO, Sayonara; GRINSZTEJN, Beatriz et al.AIDS (Supplement). 2005, Vol 19, pp S22-S26, issn 1350-2840, SUP4Article

  • Page / 12